ESSEX PHARMA DEVELOPMENT

Essex Pharma Development GmbH specialties include pharmaceutical analytics (to include large scale stability programs), as well as bioanalytics. In 2008, the development institute โ€“ located in Waltrop near Dortmund โ€“ was acquired by Merck & Co as part of the acquisition of the former Schering-Plough Corporation. Outside of the USA and Canada, the new Merck & Co. Inc. takes the corporate name โ€œMSD.โ€ The corporation is one of the worldโ€™s largest providers of innovative medications, vaccines, biological therapeutic preparations, consumer health products and veterinarian health products.

#SimilarOrganizations #More

ESSEX PHARMA DEVELOPMENT

Industry:
Analytics Health Care Life Science

Address:
Waltrop, Nordrhein-Westfalen, Germany

Country:
Germany

Status:
Active


Similar Organizations

gebro-pharma-logo

Gebro Pharma

Gebro Pharma is a developed into an internationally significant pharmaceutical company.

More informations about "Essex Pharma Development"

Essex Pharma Development - Crunchbase Company Profile

Essex Pharma Development GmbH specialties include pharmaceutical analytics (to include large scale stability programs), as well as bioanalytics. In 2008, the development institute โ€“ located โ€ฆSee details»

Essex Pharma Development - PitchBook

Essex Pharma Development General Information Description. Provider of pharmaceutical research services. The company's pharmaceutical research services include pharmaceutical โ€ฆSee details»

NUVISAN GmbH acquires Essex Pharma Development - Crunchbase

Essex Pharma Development Essex Pharma Development GmbH specialties include pharmaceutical analytics. Acquiring Organization: NUVISAN GmbH NUVISAN GmbH provides โ€ฆSee details»

NUVISAN GmbH - Funding, Financials, Valuation & Investors

Jun 1, 2011 Which types of acquisition does this organization make most frequently? Show . Acquiree Name . Announced Date . Price . Transaction Name . Essex Pharma Development . โ€ฆSee details»

Nuvisan Company Profile 2024: Valuation, Investors, Acquisition

Opeartor of a contract research and development and manufacturing organization (CRO/CDMO) company based in Neu-Ulm, Germ. BPO/Outsource Services. Neu-Ulm, Germany. 615 As of โ€ฆSee details»

Essex Pharma GmbH

Explore Essex Pharma GmbH with its drug pipeline, therapeutic area, technology platform, 10 clinical trials, and 33 literature, Drug:Carboplatin, Temozolomide, Desloratadine. ... The โ€ฆSee details»

Essex Pharma GmbH, Munich, Germany - North Data

No longer Authorized signatory (4) · Sub­sidiary: Essex Animal Health Burgwedel Division of Essex Pharma GmbH, 30938 Burgwedel, Geschäftsanschrift geändert, nun: Im Langen Felde โ€ฆSee details»

13 Best Essex Based Pharmaceutical Startups and Companies to โ€ฆ

Jul 11, 2021 This article showcases our top picks for the best Essex based Pharmaceutical companies. These startups and companies are taking a variety of approaches to innovating โ€ฆSee details»

CDMO Explained: An Overview of Contract โ€ฆ

Nov 20, 2023 This is why Contract Development and Manufacturing Organisations (CDMOs) have grown to become a fundamental to the pharma ecosystem. The global Contract Manufacturing market is estimated to be โ€ฆSee details»

EssexBio

Essex Bio-Technology Limited is a bio-pharmaceutical company that develops, manufactures and commercialises genetically engineered therapeutic fibroblast growth factors (FGF), having six flagship biologics approved for a wide range โ€ฆSee details»

Pharmaceutical CDMO Market Size, Trends and Developments

The pharmaceutical CDMO market size surpassed USD 146.05 billion in 2023 is to reach USD 315.08 billion by 2034, registering at a CAGR of 7.24% from 2024 to 2034. ... Bringing novel โ€ฆSee details»

Essex Pharma Development - Crunchbase

Essex Pharma Development GmbH specialties include pharmaceutical analytics.See details»

EssexBio

Aug 15, 2022 Essex Bio-Technology Enters into Global Co-Development Agreement with Mitotech to Fund Phase 3 Clinical Trial in U.S. FDA of a First-In-Class Drug for Dry Eye โ€ฆSee details»

Essex Bio-Technology and Antikor Biopharma Forge Strategic โ€ฆ

Product and technology development and regularly presents at major international conferences. Antikor is based in the Stevenage Bioscience Catalyst Innovation Park just north of London. โ€ฆSee details»

Essex Pharma Development - Updates, News, Events, Signals

Organization. Essex Pharma Development . Connect to CRM . Save . Summary. People. Signals & News. Similar Companies. Recent News & Activity. Edit Recent News & Activity Section ...See details»

EssexBio

Hong Kong, 22 Feb 2023 Essex Bio-Technology Ltd (โ€œEssexโ€ or the โ€œGroupโ€, Stock Code: 1061.HK) today announced that two of its wholly-owned subsidiaries, Essex Bio-Investment โ€ฆSee details»

EssexBio

Jul 15, 2022 Essex Bio-Technology Ltd (โ€œEssexโ€ or the โ€œGroupโ€, Stock Code: 1061.HK) is pleased to announce that Zhuhai Essex Bio-Pharmaceutical Company Limited๏ผˆโ€œZhuhai โ€ฆSee details»

Breaking Ground for Canadaโ€™s Largest Critical Medicines ... - API

Jun 20, 2024 Expanding our level of Contract Development and Manufacturing Organization (CDMO) support, the CMPC will develop small-molecule active pharmaceutical ingredients โ€ฆSee details»

EssexBio

Zhuhai Essex Bio-Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") is an indirect wholly-owned subsidiary of Essex Bio-Technology Limited (stock code: 01061.HK). ...See details»

linkstock.net © 2022. All rights reserved